FDA Approves Bausch + Lomb’s Lotemax SM 0.38%Approvals, FDA, FDA/Regulatory, Gels, Ocular Surgery, Ocular Tissues, Ophthalmics, Postoperative inflammationThe U.S. FDA approved Bausch + Lomb’s Lotemax SM (loteprednol etabonate ophthalmic gel) 0.38%, a new gel formulation for treating postoperative inflammation and pain following ocular surgery. Read more February 25, 2019/by PR Newswire https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png 0 0 PR Newswire https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png PR Newswire2019-02-25 07:00:482019-02-25 13:23:27FDA Approves Bausch + Lomb’s Lotemax SM 0.38%